期刊文献+

重组人血管内皮生长因子和重组人骨形态发生蛋白-7对大鼠成骨细胞增殖能力的影响 被引量:1

Effects of recombinant human vascular endothelial growth factor and recombinant human bone morphogenetic protein-7 on the proliferation of rat osteoblast
下载PDF
导出
摘要 目的研究重组人血管内皮生长因子(recombinant human vascular endothelial growth factor,rhVEGF)和重组人骨形态发生蛋白-7(recombinant human bone morphogenetic protein-7,rhBMP-7)对成骨细胞增殖能力的影响。方法取大鼠颅盖骨组织块,采用改良组织块混合酶消化法培养成骨细胞,分成4组,第1组、第2组、第3组分别加3.125 ng/mL不含血清的rhVEGF培养液、50.000 ng/mL不含血清的rhBMP-7培养液、3.125 ng/mL不含血清的rhVEGF和50.000 ng/mL不含血清的rhBMP-7培养液,第4组加不含血清的培养液作为对照组,采用细胞培养技术,应用光镜、四甲基偶氮唑盐(methyl thiazolyl tetrazolium,MTT)法,分析不同浓度的rhVEGF和rhBMP-7对成骨细胞增殖的影响。结果与对照组相比,3.125 ng/mL rhVEGF和50.000 ng/mL rhBMP-7单独或者联合作用,在1、3、5 d均有促进细胞增殖的作用,与对照组的差异均有统计学意义(P<0.05),各组间比较差异也有统计学意义(P<0.05)。其中,3.125ng/mL rhVEGF和50.000ng/mL rhBMP-7单独或者两者联合作用于第3天时,成骨细胞增殖最显著。结论一定剂量的rhVEGF和rhBMP-7可明显促进成骨细胞的增殖。 Objective To study the effects of recombinant human vascular endothelial growth factor (rhVEGF) and recombinant human bone morphogenetic protein-7 (rhBMP-7) on the proliferation of rat osteoblasts. Methods Osteo- blasts were cultivated with rhVEGF and rhBMP-7 of different concentrations for 1. 3, 5 days, and divided into four groups. The first and second group contained 3. 125, 50. 000, ng/mL rhVEGF nutrient solution without serum respective- ly. The third group contained 3. 125 ng/mL rhVEGF and 50.000 ng/rnL rhBMP-7 nutrient solution without serum. The fourth group contained culture medium without serum for comparison. Cell culturing, light microscopic, methyl thiazolyl tetrazolium (MTT) assay were used to observe the effects on proliferation in the cell morphology and the cellular eytome- try of proliferation. Results rhVEGF and rhBMP-7 could stimulate the proliferation of osteoblasts. Compared with the control group, 3. 125 ng/mL rhVEGF and 50. 000 ng/mL rhBMP-7 alone or m combination could promote the cell prolif- eration in 1,3, 5 d, and the differences were statistically significant ( P 〈 0. 05 ). The differences between the groups had statistical significance (P 〈0.05). The maximal effects on proliferation was at a concentration of 3. 125 ng/mL rh- VEGF and 50.000 ng/mL rhBMP-7 alone or in combination and in the third day. Conclusion rhVEGF and rhBMP-7 could stimulate bone formation in a direct fashion by promotion of proliferation of osteoblasts.
出处 《广东牙病防治》 2013年第12期624-627,共4页 Journal of Dental Prevention and Treatment
关键词 重组人血管内皮生长因子 重组人骨形态发生蛋白-7 成骨细胞 增殖 Recombinant human vascular endothelial growth factor Recombinant human bone morphogenetic pro-tein-7 Osteoblasts Proliferation
  • 相关文献

参考文献11

  • 1Millauer B, Wizigmann-Voos S, Schnurch H,et al. High affinityVEGF binding and developmental expression suggest Flk-1 as a ma-jor regulator of vasculogenesis and angiogenesis[ J]. Cell, 1993,72(6):835-846.
  • 2Roberts AB, Spom MB, Assion RK, et al. Transforming growth fac-tor-p: rapid induction of fibrosis and angiogenesis in vivo and stimu-.lation of collagen formation in vitro [ J]. Proc Natl Acad Sci USA,1986,83(12) :4167-4171.
  • 3Spiro AS, Beil FT, Schinke T, et al. Short-term application of dexa-methasone enhances bone morphogenetic protein-7 -induced ectopicbone formation in vivo[ J]. J Trauma, 2010,69(6) : 1473-1480.
  • 4Deckers MM, van Bezooijen RL, van der Horst G, et al. Bone mor-phogenetic proteins stimulate angiogenesis through osteoblast-derivedvascular endothelial growth factor A[ J]. Endocrinology,2002,143(4):1545-1553.
  • 5Bouletreau PJ, Warren SM, Spector JA, et al. Hypoxia and VEGFup-regulate BMP-2 mRNA and protein expression in microvascularendothelial cells : implications for fracture healing[ J] . Plast Recon-str Surg, 2002,109(7) :2384-2397.
  • 6李靖,黄鲁豫,王全平,吕荣,白建萍,倪国华.改良组织块混合酶消化法成骨样细胞培养[J].中国骨伤,2003,16(11):661-663. 被引量:9
  • 7Reichert JC, Quent VM,Neth U, et al. Ovine cortical osteoblastsoutperform bone marrow cells in an ectopic bone assay [ J]. J TissueEng Regen Med, 2011,5(10):831-844.
  • 8Peng H, Usas A, Olshanski A, et al. VEGF improves, whereassFltl inhibits, BMP2-induced bone formation and bone healingthrough mo-dulation of angiogenesis [ J]. J Bone Miner Res,2005,20(11) :2017-2027.
  • 9Barr T, McNamara AJ, Sdndor GK, et al. Comparison of the osteoin-ductivity of bioimplants containing recombinant human bone morpho-genetic proteins 2 ( Infuse) and 7 ( OP-1 ) [ J]. Oral Surg Oral MedOral Pathol Oral Radiol Endod,2010,109(4) :531-540.
  • 10Burastero G, Scarft S, Ferraris C, et al. The association of humanmesenchymal stem cells with BMP-7 improves bone regeneration ofcritical-size segmental bone defects in athymic rats [ J]. Bone,2010,47(1) :117-126.

二级参考文献4

  • 1王前,钟世镇,龚文汇,欧阳钧.鼠颅盖骨成骨细胞体外培养及ALP免疫组化法鉴别纯化[J].中华骨科杂志,1995,15(6):364-366. 被引量:32
  • 2[1]Nakahara H,Bruder SP,Goldberg VM,et al.In vivo osteochondrogenic potential of cultured cells derived from the periosteum.Clin Orthop,1990,259:223-232.
  • 3[2]Hefly TJ,Stern PH,Brand JS.Enzymatic isolation of cells from neonatal calvaria using two purified enzymes from Clostridium histolyticum.Exp Cell Res,1983,149(1):227-236.
  • 4[6]Wlodarski KH.Properties and origin of osteoblasts.Clin Orthop,1990,252:276-293.

共引文献8

同被引文献13

  • 1Yang GL, He FM, Yang XF, et al. In vivo evaluation of bone-bonding ability of RGD-coated porous implant using layer-by-layer electrostatic self-assembly[J]. J Biomed Ma- ter Res A, 2009, 90(1): 175-185.
  • 2Schuler M, Owen GR, Hamilton DW, et al. Biomimetic mo- dification of titanium dental implant model surfaces using the RGDSP-peptide sequence: a cell morphology study[J]. Biomaterials, 2006, 27(21):4003 -4015.
  • 3Bagno A, Piovan A, Dettin M, et al. Human osteoblast-like cell adhesion on titanium substrates covalently functionalized with synthetic peptides[J]. Bone, 2007, 40(3):693-699.
  • 4Liu WQ, Martinez JA, Durand J, et al. RGD-mediated ad- hesive interactions are important for peripheral axon out- growth in vivo[J]. Neurobiol Dis, 2009, 34(1): 11-22.
  • 5Ryu J J, Park K, Kim HS, et al. Effects of anodized titanium with Arg-Gly-Asp (RGD) peptide immobilized via chemical grafting or physical adsorption on bone cell adhesion and differentiation[J]. Int J Oral Maxillofac Implants, 2013,28 (4):963-972.
  • 6Park JC, Lee JB, Daculsi G, et al. Novel analysis model for implant osseointegration using ectopic bone formation via the recombinant human bone morphogenetic protein-2/ma- croporous biphasic calcium phosphate block system in rats: a proof-of-concept study[J]. J Periodontal Implant Sci, 2012, 42(4):136-143.
  • 7Choi H, Park N J, Jamiyandorj O, et al. Improvement of osteogenic potential of biphasic calcium phosphate bone substitute coated with two concentrations of expressed re- combinant human bone morphogenetic protein 2[J]. J Pe- riodontal Implant Sci, 2012, 42(4): 119-126.
  • 8Willett N J, Li MT, Uhrig BA, et al. Attenuated human bone morphogenetic protein-2-mediated bone regeneration in a rat model of composite bone and muscle injury[J]. Tissue Eng Part C Methods, 2013, 19(4):316-325.
  • 9Kroese-Deutman HC, van den Dolder J, Spauwen PH, et al. Influence of RGD-loaded titanium implants on bone for- mation in vivo[J]. Tissue Eng, 2005, 11(11/12):1867-1875.
  • 10Chen WC, Ko CL. Roughened titanium surfaces with silane and further RGD peptide modification in vitro[J]. Mater Sci Eng C Mater Biol Appl, 2013, 33(5):2713-2722.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部